Weight gain in bipolar disorder: pharmacological treatment as a contributing factor

Carla Torrent; Benedikt L. Amann; José Sánchez‐Moreno; Francesc Colom; María Reinares; Mercé Comes; Adriane Ribeiro Rosa; Jan Scott; Eduard Vieta

doi:10.1111/j.1600-0447.2008.01204.x

Abstract

1 min read

Careful monitoring of weight changes in patients before and after drug prescription should be implemented in the clinical routine and drugs which potentially cause weight gain should be avoided in overweight patients with bipolar disorder. Furthermore, eating habits and daily activities should be targeted as they may also have a significant impact on overall health and weight-related issues.

Related publications

Article2004

Effects on Weight and Outcome of Long-term Olanzapine-Topiramate Combination Treatment in Bipolar Disorder

Eduard Vieta, José Sánchez‐Moreno, José Manuel Goikolea, Francesc Colom, Anabel Martínez‐Arán, Antonio Benabarre, Bàrbara Corbella, Carla Torrent, Mercé Comes, María Reinares, Esteve Brugué

Article2001

Olanzapine as Long-Term Adjunctive Therapy in Treatment-Resistant Bipolar Disorder

Eduard Vieta, María Reinares, Bàrbara Corbella, Antoni Benabarre, Inmaculada Gilaberte, Francesc Colom, Anabel Martínez‐Arán, Cristòbal Gastó, M. Tohen

Article2018

Early Intervention in Bipolar Disorder

Eduard Vieta, Estela Salagre, Iría Grande, André F. Carvalho, Brisa S. Fernandes, Michael Berk, Boris Birmaher, Mauricio Tohen, Trisha Suppes

Letter2009

The influence of medications on neurocognition in bipolar disorder

Eduard Vieta

Article2010

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism

Azorin Jm, C. Bowden, RP Garay, Giulio Perugi, Eduard Vieta, Allan H. Young